Ticker LaunchReverse merger · Completed
Lomond Therapeutics, Inc.
Reverse merger with Venetian-1 Acquisition Corp.
Lomond Therapeutics, Inc. merged into Venetian-1 Acquisition Corp., a shell company, in a reverse merger that takes the private company public. The agreement was signed and the deal closed on the same day, Nov 1, 2024. The combined company trades as Lomond Therapeutics Holdings, Inc..
- Status
- Completed
- Private company
- Lomond Therapeutics, Inc.
- Public company
- Venetian-1 Acquisition Corp.
- Public company business before
- shell company
- Announced
- Signed and closed the same day
- Closed
- Nov 1, 2024
- Combined company
- Lomond Therapeutics Holdings, Inc.
- Sector
- Biotech & pharma
More on this deal for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Nov 7, 2024
- Closing exhibit
- Announcement 8-K Nov 7, 2024
- All filings on EDGAR CIK 1900520
Other completed reverse mergers
- Xinghe Technology Limitedinto Jingbo Technology, Inc. · Dec 12, 2024
- TuHURA Biosciences, Inc.into Kintara Therapeutics, Inc. · Oct 18, 2024
- NAYA Biosciences, Inc.into INVO Bioscience, Inc. · Oct 11, 2024
- Pharmagesic (Holdings) Inc. (Wex Pharmaceuticals)into Virios Therapeutics, Inc. · Oct 7, 2024
- OnKure, Inc.into Reneo Pharmaceuticals, Inc. · Oct 4, 2024
- Polomar Specialty Pharmacy, LLCinto Trustfeed Corp. · Sep 30, 2024